Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2007 3
2008 4
2009 7
2010 6
2011 9
2012 15
2013 9
2014 10
2015 16
2016 15
2017 13
2018 16
2019 14
2020 9
2021 16
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Results by year
Filters applied: . Clear all
Page 1
Pathways to Alzheimer's disease.
Hardy J, Bogdanovic N, Winblad B, Portelius E, Andreasen N, Cedazo-Minguez A, Zetterberg H. Hardy J, et al. Among authors: portelius e. J Intern Med. 2014 Mar;275(3):296-303. doi: 10.1111/joim.12192. J Intern Med. 2014. PMID: 24749173 Free article. Review.
Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, Cash DM, Coath W, Lane CA, Parker TD, Lu K, Buchanan SM, Keuss SE, James SN, Murray-Smith H, Wong A, Barnes A, Dickson JC, Heslegrave A, Portelius E, Richards M, Fox NC, Zetterberg H, Blennow K, Schott JM. Keshavan A, et al. Among authors: portelius e. Brain. 2021 Mar 3;144(2):434-449. doi: 10.1093/brain/awaa403. Brain. 2021. PMID: 33479777 Free PMC article.
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Alić I, Goh PA, Murray A, Portelius E, Gkanatsiou E, Gough G, Mok KY, Koschut D, Brunmeir R, Yeap YJ, O'Brien NL, Groet J, Shao X, Havlicek S, Dunn NR, Kvartsberg H, Brinkmalm G, Hithersay R, Startin C, Hamburg S, Phillips M, Pervushin K, Turmaine M, Wallon D, Rovelet-Lecrux A, Soininen H, Volpi E, Martin JE, Foo JN, Becker DL, Rostagno A, Ghiso J, Krsnik Ž, Šimić G, Kostović I, Mitrečić D; LonDownS Consortium, Francis PT, Blennow K, Strydom A, Hardy J, Zetterberg H, Nižetić D. Alić I, et al. Among authors: portelius e. Mol Psychiatry. 2021 Oct;26(10):5766-5788. doi: 10.1038/s41380-020-0806-5. Epub 2020 Jul 10. Mol Psychiatry. 2021. PMID: 32647257 Free PMC article.
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, Brinkmalm G, Hye A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: portelius e. Biomark Med. 2018 Jul;12(7):799-812. doi: 10.2217/bmm-2017-0433. Epub 2018 Jun 15. Biomark Med. 2018. PMID: 29902934 Review.
Clinical proteomics in neurodegenerative disorders.
Zetterberg H, Rüetschi U, Portelius E, Brinkmalm G, Andreasson U, Blennow K, Brinkmalm A. Zetterberg H, et al. Among authors: portelius e. Acta Neurol Scand. 2008 Jul;118(1):1-11. doi: 10.1111/j.1600-0404.2007.00985.x. Epub 2008 Feb 13. Acta Neurol Scand. 2008. PMID: 18279484 Review.
Amyloid pathology and synaptic loss in pathological aging.
Gkanatsiou E, Nilsson J, Toomey CE, Vrillon A, Kvartsberg H, Portelius E, Zetterberg H, Blennow K, Brinkmalm A, Lashley T, Brinkmalm G. Gkanatsiou E, et al. Among authors: portelius e. J Neurochem. 2021 Oct;159(2):258-272. doi: 10.1111/jnc.15487. Epub 2021 Sep 2. J Neurochem. 2021. PMID: 34473357 Free article.
Explorative and targeted neuroproteomics in Alzheimer's disease.
Brinkmalm A, Portelius E, Öhrfelt A, Brinkmalm G, Andreasson U, Gobom J, Blennow K, Zetterberg H. Brinkmalm A, et al. Among authors: portelius e. Biochim Biophys Acta. 2015 Jul;1854(7):769-78. doi: 10.1016/j.bbapap.2015.01.009. Epub 2015 Jan 22. Biochim Biophys Acta. 2015. PMID: 25619854 Review.
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
Nilsson J, Gobom J, Sjödin S, Brinkmalm G, Ashton NJ, Svensson J, Johansson P, Portelius E, Zetterberg H, Blennow K, Brinkmalm A. Nilsson J, et al. Among authors: portelius e. Alzheimers Dement (Amst). 2021 May 1;13(1):e12179. doi: 10.1002/dad2.12179. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 33969172 Free PMC article.
153 results